IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
54.65
+1.30 (2.44%)
Dec 20, 2024, 4:00 PM EST - Market closed
IRADIMED CORPORATION Revenue
IRADIMED CORPORATION had revenue of $18.33M in the quarter ending September 30, 2024, with 11.04% growth. This brings the company's revenue in the last twelve months to $71.31M, up 13.23% year-over-year. In the year 2023, IRADIMED CORPORATION had annual revenue of $65.56M with 23.00% growth.
Revenue (ttm)
$71.31M
Revenue Growth
+13.23%
P/S Ratio
9.70
Revenue / Employee
$481,791
Employees
148
Market Cap
692.60M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 65.56M | 12.26M | 23.00% |
Dec 31, 2022 | 53.30M | 11.49M | 27.48% |
Dec 31, 2021 | 41.81M | 10.10M | 31.83% |
Dec 31, 2020 | 31.72M | -6.80M | -17.65% |
Dec 31, 2019 | 38.52M | 8.08M | 26.54% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Orthofix Medical | 784.25M |
Bioventus | 555.06M |
Axogen | 180.86M |
CureVac | 70.57M |
Dianthus Therapeutics | 5.37M |
Keros Therapeutics | 651.00K |
IRMD News
- 2 days ago - IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 11 days ago - IRADIMED CORPORATION on Forbes' List of America's Most Successful Small-Cap Companies for 2025 - GlobeNewsWire
- 6 weeks ago - IRADIMED CORPORATION Named to Fortune's 100 Fastest Growing Companies List for 2024 - GlobeNewsWire
- 7 weeks ago - IRADIMED CORPORATION (IRMD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share - GlobeNewsWire
- 2 months ago - IRADIMED CORPORATION to Hold 2024 Third Quarter Financial Results Conference Call on October 31st - GlobeNewsWire
- 2 months ago - IRADIMED CORPORATION to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewsWire
- 3 months ago - IRADIMED CORPORATION To Participate in the Lake St. Annual Best Ideas Growth “Big 8” Investor Conference - GlobeNewsWire